Back to Careers
CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream
Back to Careers
Longevity Technology highlights Juvena and others from the Longevity Summer Dublin
Back to Careers
AFAR: AI For Longevity Drug Discovery: Breakthrough and Challenges Webinar
Back to Careers
Dr. Jeremy O’Connell, Director of translation Dr. Priya Handa, and Scientist Dr. Ritwik Datta attend and present our latest results at ENDO 2024, highlighting how JUV-112 Offers a Distinctive Approach to Weight Loss and Metabolic Health
Back to Careers
Dr. Jeremy O’Connell, Director of translation Dr. Priya Handa, and Scientist Dr. Ritwik Datta attend and present our latest results at ENDO 2024, highlighting how JUV-112 Offers a Distinctive Approach to Weight Loss and Metabolic Health
Back to Careers
Juvena’s Director of Discovery & Platform, Dr. Thach Mai presents “Mapping the therapeutic potential of secreted proteins through integrating AI and quantitative multi-omics technology” at the Element Biosciences Roadshow
Back to Careers
CEO and co-Founder Dr. Hanadie Yousef recognized as In Vivo’s 2024 Rising Leaders, which includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.
Back to Careers
One of In Vivo’s 2024 Rising Leaders, Dr. Hanadie Yousef, CEO of Juvena Therapeutics, talks about the secretome as a source of therapeutics, the company’s lead assets, the future of longevity medicine and learning as you go as a biotech entrepreneur.
Back to Careers
Juvena’s CMO Dr. Barney King participates in the Myotonic Dystrophy Regional Summit, where Juvena gave an industry presentation.
Back to Careers
CEO Dr. Hanadie Yousef participates in a panel on “Demystifying Aging” at Horizons Ventures 2024 Techcracker summit
